Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes Gilbert R. Thompson, Mary Seed, Rossi P. Naoumova, Clare Neuwirth, Shahenaz Walji, Timothy J. Aitman, James Scott, Nicolas B. Myant, Anne K. Soutar Atherosclerosis Volume 243, Issue 1, Pages 328-333 (November 2015) DOI: 10.1016/j.atherosclerosis.2015.09.029 Copyright © 2015 Elsevier Ireland Ltd Terms and Conditions
Fig. 1 Comparison of pre- and on-treatment serum total cholesterol (TC) in dead and alive FH homozygotes. The on-treatment TC in patients who were on apheresis was calculated as the mean of the pre-procedure values. Atherosclerosis 2015 243, 328-333DOI: (10.1016/j.atherosclerosis.2015.09.029) Copyright © 2015 Elsevier Ireland Ltd Terms and Conditions